Valerie BILLARD

Dr. Valerie BILLARD

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2016 in Anaesthesia Critical Care & Pain Medicine
Verified
Journal Article
Closed access
NCNora Colegrave
Nora Colegrave
VBValerie BILLARD
Valerie BILLARD
CMcyrus Motamed
cyrus Motamed
JBJean-Louis Bourgain
Jean-Louis Bourgain

19 February 2004 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
PDF file
VBValerie BILLARD
Valerie BILLARD
FSF. Servin
F. Servin
BGB. Guignard
B. Guignard
EJE. Junke
E. Junke
MBM. N. Bouverne
M. N. Bouverne
MCM. Chauvin
M. Chauvin

28 October 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CMcyrus Motamed
cyrus Motamed
FPFrederic Plantevin
Frederic Plantevin
JMJean-Xavier Mazoit
Jean-Xavier Mazoit
MJMorbize Julieron
Morbize Julieron
JBJean Louis Bourgain
Jean Louis Bourgain
VBValerie BILLARD
Valerie BILLARD
Introduction: Pain after cervicofacial cancer surgery with free flap reconstruction is both underestimated and undertreated. There is a rational for regional anesthesia at the flap harvest site, but few studies describe it. We assessed the influence of common peroneal nerve infiltration on pain and opioid consumption in patients having oropharyngeal cancer surgery with fibular free flap mandibular reconstruction. Methods: After institutional review board (IRB) approval and written informed consent, fifty-six patients were randomly allocated to perineural catheter with ropivacaine infiltration (ROPI) or systemic analgesia (CONTROL). In the ROPI group, an epidural catheter was placed by the surgeon before closure, and ropivacaine 0.2% 15 mL, followed by 4 mL/h during 48 h, was administered. The primary outcomes were pain scores and morphine consumption during the 48 h postoperative period. We also measured ropivacaine concentration at the end of infusion. Finally, we retrospectively assessed long-term pain up to 10 years using electronic medical charts. Results: Perineural infiltration of ropivacaine significantly reduced pain scores at the harvest site only at day 1, and did not influence overall postoperative opioid consumption. Ropivacaine assay showed a potentially toxic concentration in 50% of patients. Chronic pain was detected at the harvest site in only one patient (ROPI group), and was located in the cervical area in the case of disease progression. Discussion: Although the catheter was visually positioned by the surgeon, continuous ropivacaine infiltration of the common peroneal nerve did not significantly reduce postoperative pain, but induced a blood concentration close to the toxic threshold at day 2. Further studies considering other infiltration locations or other dosing schemes should be tested in this context, both to improve efficacy and reduce potential toxicity.

15 September 2022 in Medicina
Verified
Journal Article
Open access
PDF file
CMcyrus Motamed
cyrus Motamed
FSFrederique Servin
Frederique Servin
VBValerie BILLARD
Valerie BILLARD
Backgroundand Objectives: Remifentanil-based sedation is one of many protocols proposed for endoscopy procedures in spontaneous ventilation, alone or in combination with propofol. However, the effect of these small doses of propofol on the efficacy and safety of remifentanil target-controlled infusion (TCI) deserves to be examined in this context. The objective of this study was to assess the adverse respiratory and cardiovascular effects of small boluses of propofol combined with remifentanil, in comparison with remifentanil alone, and balanced with the quality of sedation and recovery. Materials andMethods: This was an observational bicenter study, representing a subgroup of a larger study describing remifentanil-based procedural sedation. In center 1, patients scheduled for gastrointestinal (GI) endoscopy had remifentanil TCI alone. In center 2, patients had a 10 mg propofol bolus before TCI and other boluses were allowed during the procedure. Remifentanil TCI was started at a target of 2 ng/mL then adapted by 0.5 ng/mL steps according to patient response to endoscopy stimulations. Results: Center 1 included 29 patients, while center 2 included 60 patients. No difference was found in the patients’ characteristics, incidence of success, average remifentanil consumption, or cardiovascular variables. Light sedation was achieved when propofol was added. The incidence of respiratory events, such as bradypnea, desaturation < 90%, and apnea requiring rescue maneuvers, were significantly higher with propofol. Conclusions: Adding propofol boluses to a remifentanil TCI for GI endoscopy ensures light sedation that may be necessary for anxiolysis but increases respiratory events, even after administration of small-dose boluses. Its safety is acceptable if the procedure is performed in an equipped environment with sedation providers trained to manage respiratory events and drugs titrated to minimal doses.

1 September 2021 in Anesthésie & Réanimation
Verified
Journal Article
Closed access
FSFrédérique Servin
Frédérique Servin
VBValerie BILLARD
Valerie BILLARD